DOI QR코드

DOI QR Code

Mortality and Potential Years of Life Lost of Colorectal cancer between Korea and OECD countries before and after the year 2000

우리나라와 OECD 국가 간의 2000년 전과 후 대장암 사망률과 잠재수명손실연수에 관한 비교

  • Kim, Dong-Seok (Department of Medical Management, Gimcheon University) ;
  • Kang, Soo-Won (Department of Medical Management, Gimcheon University)
  • 김동석 (김천대학교 의료경영학과) ;
  • 강수원 (김천대학교 의료경영학과)
  • Received : 2012.08.20
  • Accepted : 2012.11.08
  • Published : 2012.11.30

Abstract

The present study is designed to compare the mortality and potential years of life lost of colorectal cancer between OECD countries and Korea before (1990-1999) and after (2000-2009) to provide data of more accurate strategy of public health policy and education about cancer treatment and prevention through examining differences of changes among the OECD countries. We statistically compared mortality and potential years of life lost from 32 OECD countries including Korea, except 2 nations with inadequate data, between before (1990-1999) and after the year 2000 (2000-2009) using 'OECD Health Data 2012' using the method of paired t-test. Male mortality of colorectal cancer was increased in 8 OECD countries including Korea and the female mortality was only increased in Chile and Korea. In particular, the increased rate of mortality was significantly high in Korean male and female. Moreover, increased rate of potential years of life lost for colorectal cancer was also significantly high in Korea: the rate in Korean male was increased over three times than in Mexico (2nd rank of the increase) and the rate of female was only increased in Korea compared with other countries, interestingly. Therefore, the present study suggested that most OECD countries well controlled the incidence and treatment of colorectal cancer after 2000 but Korea did not. From these, to control future problems, the further studies for the reason of the increase of potential years of life lost in female will be needed.

이 연구의 목적은 우리나라의 악성신생물 중 최근 증가율이 가장 높은 대장암에 대하여 우리나라와 OECD 국가들 간에 2000년 전(1990-1999)과 2000년 후(2000-2009)의 사망률과 잠재수명손실연수(PYLL)에 통계학적으로 차이가 있는가를 살펴본 후, 대장암에 대한 국가 간 비교와 변화의 추이를 파악하여, 보건정책, 보건교육 등을 위한 자료를 제공하고자 하였다. "OECD Health Data 2012"을 사용하여 OECD 회원국 중 자료가 불충분한 2개국을 제외한 32개국에 대하여 대응표본 T검정(Paired T test) 방법을 사용해서 2000년 전과 2000년 후에 통계학적으로 차이를 살펴보았다. 남자의 대장암 사망률은 우리나라를 포함한 8개국만 2000년 후에 증가하였고, 여자의 대장암 사망률은 우리나라와 칠레만 증가하였는데 증가폭은 남녀 모두 우리나라가 월등히 높았다. 대장암 잠재수명손실연수는 2000년후에 증가폭이 우리나라가 월등히 높았는데, 남성의 경우 증가율 2위인 멕시코보다 3배 이상 증가하였고, 여성의 경우 2000년 후에 통계학적으로 유의하게 잠재수명손실연수가 증가한 나라는 우리나라가 유일하였다. 따라서, 대부분 OECD 국가는 2000년 이후 대장암 관리가 적절히 통제되고 있는 반면, 우리나라는 그렇지 못한 것으로 보이며, 특히 향후관리에 있어 여성에서 보인 잠재수명손실연수의 증가 이유에 관한 후속연구가 필요해 보인다.

Keywords

References

  1. Hanlon JJ, Packett GE. "Public health administration and practice". Mirror/Mosby. pp.230-232. 1984.
  2. Lee DW. "An analysis cause of death from the reported death certificates in Korea". Korean Journal df Preventive Medicine, 14(1), 39-42. 1981.
  3. Statistics Korea.. "Cause of death statistics Statistics". Statistics Korea. 2011.
  4. World Health Organization. "The 10 leading causes of death by broad income group, 2008. 2012. Available from:http://www.who.int/mediacentre/factsheets/fs310
  5. Yabroff KR, Bradley CJ, Mariotto AB, Brown ML, Feuer EJ. "Estimates and projections of value of life lost from cancer deaths in the United States". Journal of the National Cancer Institute, 100(24); 1755-1762. 2008.. https://doi.org/10.1093/jnci/djn383
  6. Savidana A, Junkerb C, Cernyc T. "Premature deaths in Switzerland from 1995-2006 causes and trends". doi:10.4414/smw.2010.13077. 2010.
  7. Wheller L, Baker A, Griffiths C. "Trends in premature mortality in England and Wales, 1950- 2004". Health Statistics Quarterly, 31; 34-41. 2006.
  8. OECD. "Health at a glance. 20011". OECD Publishing. pp. 17-19. 2001
  9. Romeder JM, McWhinnie JR. "Potential years of life lost between ages 1 and 70: an indicator of premature mortality for health planning". International Journal of Epidemiology, 6(2); 143-51. 1977. https://doi.org/10.1093/ije/6.2.143
  10. Savidana A, Junkerb C, Cernyc T. "Premature deaths in Switzerland from 1995-2006 causes and trends". doi:10.4414/smw.2010.13077. 2010.
  11. U.S. Department of Health and Human Services. Centers for Disease Control and Prevention.National Center for Health Statistics. "Health United States, 2011-with special feature death and dying". Washington. U.S. Government Printing Office. 2011.
  12. OECD. "OECD Health Data 2011 - Frequently Requested Data". 2012". Available from: http://www.oecd.org/statisticsdata/0,3381,en_2649_33929_1_119656_1_1_1,00.html
  13. YU SH, Yang JM. "Medical Overview", SooMoon Publishing, p. 138, 1994
  14. OECD. "Health at a glance 2001". OECD Publishing. 2001.
  15. OECD. "Health at a Glance 2011". OECD Publishing. 2011
  16. OECD. "OECD Health Data 2011 - Frequently Requested Data". 2012. Available from: http://www.oecd.org/statisticsdata/0,3381,en_2649_33929_1_119656_1_1_1,00.html
  17. Jung KW, Park S, Won YJ, Kong HJ, Lee JY, Park EC, Lee JS. "Prediction of cancer incidence and mortality in Korea, 2011" Cancer Research and Treatment, 43(1); 12-18. 2011. https://doi.org/10.4143/crt.2011.43.1.12
  18. Jung KW, Park S, Won YJ, Kong HJ, Lee JY, Seo HG, Lee JS. "Prediction of cancer incidence and mortality in Korea, 2012". Cancer, Research and Treatment, 44(1); 25-31. 2012. https://doi.org/10.4143/crt.2012.44.1.25
  19. Matsuda T, Zhang M. "Comparison of Time Trends in Colorectal Cancer Mortality(1990-2006) in the World, from the WHO Mortality Database". Japanese Journal of Clinical Oncology, 39(11); 777-778. 2009. https://doi.org/10.1093/jjco/hyp152
  20. Ribes J, Navarro M, Cleries R, Esteban L, Pareja L, Borras JM. "Colorectal cancer mortality in Spain: trends and projections for 1985-2019". European Journal of Gastroenterology & Hepatology, 21(1); 92-100. 2009. https://doi.org/10.1097/MEG.0b013e32830b5f39
  21. Centers for Disease Control and Prevention. Prevalence of Doctor-Diagnosed Arthritis and Arthritis-Attributable Activity Limitation - United States, 2007-2009". MMWR Morbidity and Mortality Weekly Report, 59(39); 1260-1295. 2010. .
  22. Vogelaar I, van Ballegooijen M, Schrag D, Boer R, Sidney J, Winawern SJ, Habbema JDF, Zaube AG. "How Much Can Current Interventions Reduce Colorectal Cancer Mortality in the U.S.? Mortality Projections for Scenarios of Risk-Factor Modification, Screening, and Treatment". CANCER, 107(7); 1624-1633. 2006. https://doi.org/10.1002/cncr.22115
  23. Savidana A, Junkerb C, Cernyc T. "Premature deaths in Switzerland from 1995-2006 causes and trends",doi:10.4414/smw.2010.13077. 2010.
  24. U.S. Department of Health and Human Services.Centers for Disease Control and Prevention.National Center for Health Statistics. "Health United States, 2011-with special feature death and dying". Washington. U.S. Government Printing Office. 2011
  25. Vogelaar I, van Ballegooijen M, Schrag D, Boer R, Sidney J, Winawer SJ, Habbema JDF, Zaube AG. "How Much Can Current interventions Reduce Colorectal Cancer Mortality in the U.S.?". CANCER 107(7); 1624-1633. 2006. https://doi.org/10.1002/cncr.22115
  26. World Health Organization. "Global heath risks, mortality and burden of disease attributable to selected major risks". WHO Press. p. 18.
  27. Minister of Health and Welfare. "2011 Yearbook of Health and Welfare Statistics". Minister of Health and Welfare. p. 29. 2011.
  28. OECD. "2009 OECD Health data(CD-ROM)". OECD. 2010.
  29. Food and Agriculture Organization. "2009 The State of Food and Agriculture". FAO(Rome). pp. 10-11. 2009.
  30. Mun OL. "Health insurance" Shinkwangpub. pp. 41-48. 2009.
  31. YU SH, Park EC. "Health insurance" Shinkwangpub. pp. pp. 223-239. 2010.

Cited by

  1. Effects of phosphorylated cross-linked resistant corn starch on the intestinal microflora and short chain fatty acid formation during in vitro human fecal batch culture vol.22, pp.6, 2013, https://doi.org/10.1007/s10068-013-0262-y